Sign In
Buy BLUE
$4.97
+0 (+0%)
At Close: Aug 29, 2025
bluebird bio Announces That Its 2020 Annual Meeting of Stockholders Will Be Held in Virtual Format
08:05pm, Wednesday, 03'rd Jun 2020
bluebird bio, Inc. (NASDAQ: BLUE) today announced that, due to the public health and safety concerns related to the novel coronavirus (COVID-19) pandemic, to support the health and well-being of its d
Global Sickle Cell Disease Clinical Trial Pipeline Highlights 2020 - ResearchAndMarkets.com
12:00am, Friday, 29'th May 2020
The
Morgan Stanley Maintains Equal-Weight on bluebird bio, Raises Price Target to $73
12:05pm, Thursday, 28'th May 2020bluebird bio Announces Live Webcast of EHA Data Review and June Investor Events
12:00pm, Thursday, 28'th May 2020
bluebird bio, Inc. (NASDAQ: BLUE) today announced that the company will host a live webcast to review new data presented at the European Hematology Association (EHA) Annual Meeting on Friday, June 12
SVB Leerink Maintains Outperform on bluebird bio, Raises Price Target to $129
10:55am, Thursday, 28'th May 2020Foresite Capital Management IV, LLC Buys Biohaven Pharmaceutical Holding Co, bluebird bio Inc, ...
12:00am, Thursday, 28'th May 2020What Sanofi Might Buy With Its Regeneron Windfall
02:35pm, Wednesday, 27'th May 2020
The drug company has not said what it plans to do with the cash, but analysts speculate that it will pursue a gene therapy company worth around $5 billion.
Bristol-Myers Analyst Says 'Big 7' Pipeline Assets Hold $15B In Peak Sales Potential
12:00am, Wednesday, 27'th May 2020
Biopharma companies are among the most resilient among sectors during the coronavirus pandemic, and one large-cap biopharma has a slew of products in its pipeline that have...
Bluebird (BLUE) Upgraded to Buy: What Does It Mean for the Stock?
04:00pm, Monday, 25'th May 2020
Bluebird (BLUE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
FDA Mishaps Have Investors Asking “What’s Going On With bluebird bio?”
03:10pm, Friday, 22'nd May 2020
Between a string of avoidable problems and instability in the market, bluebird bio might be in for a rough decade.
8 Biotechs Tapping Secondary Markets for $3 Billion
10:53pm, Tuesday, 19'th May 2020
Company stocks drop on dilution, but monies could benefit shareholders down the line Continue reading...
Bluebird Prices New Shares At $55, Seeks To Raise $500 Million
11:19am, Tuesday, 19'th May 2020
Bluebird Bio (BLUE) priced an offering of 9.09 million shares of its common stock at $55 each, the company said late on Monday.The gene therapy company, which expects the offering to close on May 21,
bluebird bio Announces Pricing of Public Offering of Common Stock
01:32am, Tuesday, 19'th May 2020
bluebird bio, Inc. (Nasdaq: BLUE) today announced the pricing of an underwritten public offering of 9,090,910 shares of its common stock at a public offering price of $55.00 per share, before underwri
